Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer
about
Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of CancerA highly accurate inclusive cancer screening test using Caenorhabditis elegans scent detectionThe scent of disease: volatile organic compounds of the human body related to disease and disorderPyrazine analogues are active components of wolf urine that induce avoidance and freezing behaviours in miceAvian influenza infection alters fecal odor in mallardsNoninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.Cellular scent of influenza virus infection.A micro-extraction technique using a new digitally controlled syringe combined with UHPLC for assessment of urinary biomarkers of oxidatively damaged DNA.Biomarkers for Detection and Monitoring of B16 Melanoma in Mouse Urine and Feces.Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.Analysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice.Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer.Volatile Organic Metabolites Identify Patients with Mesangial Proliferative Glomerulonephritis, IgA Nephropathy and Normal Controls.Targeting Bcl-2 stability to sensitize cells harboring oncogenic rasAlterations of the volatile metabolome in mouse models of Alzheimer's disease.Brain Injury Alters Volatile Metabolome.The state of molecular biomarkers for the early detection of lung cancer.Comparative analysis of volatile metabolomics signals from melanoma and benign skin: a pilot study.Nicotine increases the resistance of lung cancer cells to cisplatin through enhancing Bcl-2 stability.Nuclear magnetic resonance-based analysis of urine for the rapid etiological diagnosis of pneumonia.Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry.Electronic Olfactory Sensor Based on A. mellifera Odorant-Binding Protein 14 on a Reduced Graphene Oxide Field-Effect TransistorGC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.Sniffer mice discriminate urine odours of patients with bladder cancer: A proof-of-principle study for non-invasive diagnosis of cancer-induced odours.Animal instinct helps doctors ferret out disease.Thermotropic Liquid Crystal-Assisted Chemical and Biological Sensors.Detecting bladder cancer using volatile analyses: is this the future?Prostate cancer diagnosis through electronic nose in the urine headspace setting: a pilot study.Analysis of volatile organic compounds in pleural effusions by headspace solid-phase microextraction coupled with cryotrap gas chromatography and mass spectrometry.A Proof of Concept: Are Detection Dogs a Useful Tool to Verify Potential Biomarkers for Lung Cancer?The volatilome - investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC).
P2860
Q26796389-EB89EB16-4EEC-4E05-A9AF-124B2AD6D428Q27313319-F83AD044-C6A6-49CB-B808-2C6FFAB9C7ABQ28243639-7F1B5D18-076F-4248-8EAB-AAA14272048EQ28486847-4D3A9F80-7259-4AEA-952C-0C3855DD9AF3Q28534430-B2C9AA7C-217E-44F8-94B4-9E3ECEDD8DFEQ33909660-DDC2E7D4-65E2-4764-A020-186EB4529193Q33923347-8C316DA1-14DC-483A-B032-F3C68FA16B3EQ34618810-2D3C067C-428C-4A16-B5AE-D9EDDE556C7CQ35623580-90E772E9-6612-48E6-B191-5EA91BBF8109Q35653903-4F4B733E-CFBD-4CF2-9C92-0D898D237B21Q35854350-F0134887-A087-4DC8-BED2-D3128F7ABE1CQ35876957-48E80CF1-AE22-4BB1-A2BF-D13CC206F25DQ36129126-E12669A3-1428-49A9-B510-472BE1DAE880Q36355952-7D52B8A8-2604-41C2-8A5F-979627150EE9Q36499354-0D2CB140-1840-4965-8B32-C50806CFC78BQ37012430-33F9BB0E-D280-43DC-9B55-4DDCA41EFEF8Q37044593-5ABBF4CD-5403-48E9-A1A4-207D162103F1Q37161693-FEBB4DC2-A06D-4294-B87C-FE5DEB8AD09DQ37681772-41C9BEA2-2A82-43C2-9453-7D39BF73A46DQ38088723-2CC9CEB1-254F-4DD8-AC26-E2186B2442D5Q38103592-0C4B8581-75A6-41B6-86C1-15011D82D89CQ38646944-442C2252-36D4-444C-BF9E-656514C88016Q38853863-6B92AE7C-4C4A-47A4-9380-8C3F26E7B209Q45950402-D85F81A9-BA1A-4A55-A95E-1DB2E1F40246Q48155290-B244357A-D819-41AA-908D-C23A1E2F9236Q48319942-E6762E92-555A-4133-81EF-2F4AA2C70D52Q48809230-C53EFE82-41E1-4D66-AD4D-60204C2507E2Q51324731-A5F65F2A-894F-412A-9848-BA41342ECA79Q51339787-22AB2912-5A63-4233-B3E7-3B08F04AFA22Q52806432-2D00A16B-EDC6-4578-BE2C-6D30DAA8F09BQ55518015-46DE442B-A2F6-4461-97E9-FB185A380E37
P2860
Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Urinary volatile compounds as ...... in mouse models of lung cancer
@ast
Urinary volatile compounds as ...... in mouse models of lung cancer
@en
Urinary volatile compounds as ...... in mouse models of lung cancer
@nl
type
label
Urinary volatile compounds as ...... in mouse models of lung cancer
@ast
Urinary volatile compounds as ...... in mouse models of lung cancer
@en
Urinary volatile compounds as ...... in mouse models of lung cancer
@nl
prefLabel
Urinary volatile compounds as ...... in mouse models of lung cancer
@ast
Urinary volatile compounds as ...... in mouse models of lung cancer
@en
Urinary volatile compounds as ...... in mouse models of lung cancer
@nl
P2093
P2860
P1433
P1476
Urinary volatile compounds as ...... in mouse models of lung cancer
@en
P2093
Anil Vachani
Gary K Beauchamp
Hiroaki Oka
Koichi Matsumura
Kunio Yamazaki
Maryanne Opiekun
Steven M Albelda
P2860
P356
10.1371/JOURNAL.PONE.0008819
P407
P577
2010-01-27T00:00:00Z